Survey and Research Archives | Page 15 of 142 | Be Korea-savvy

Archive by category Survey and Research

Crinetics Announces FDA Approval of PALSONIFY™ (paltusotine) for the Treatment of Adults with Acromegaly

Crinetics Announces FDA Approval of PALSONIFY™ (paltusotine) for the Treatment of Adults with Acromegaly

Novel nonpeptide SST2 agonist PALSONIFY advances the treatment paradigm as the first once-daily, oral therapy approved by the FDA to treat acromegaly Approval based on data from two pivotal Phase 3 trials where PALSONIFY was well tolerated and resulted in rapid, durable, and consistent biochemical control and reduced symptom burden Launch of lead product PALSONIFY [...]

Cloudera Survey Finds 96% of Enterprises Have Integrated AI Into Core Business Processes, Signaling AI Has Moved from Competitive Advantage to Mandatory Practice

Cloudera Survey Finds 96% of Enterprises Have Integrated AI Into Core Business Processes, Signaling AI Has Moved from Competitive Advantage to Mandatory Practice

Enterprises report stronger results from AI adoption, while hybrid data architecture emerges as key enabler of secure, scalable AI at enterprise scale SANTA CLARA, Calif., Sept. 25, 2025 (Korea Bizwire) – Cloudera, the only company bringing AI to data anywhere, today released findings from its latest global survey report, The Evolution of AI: The State of Enterprise [...]

Denodo Users Gain 345% ROI, 3–4x Faster Time-to-Insight, and Other Advantages, When Deployed alongside a Data Lakehouse

Denodo Users Gain 345% ROI, 3–4x Faster Time-to-Insight, and Other Advantages, When Deployed alongside a Data Lakehouse

Study conducted by Veqtor8 finds delayed projects and $millions at risk when enterprises operate lakehouses without a logical data layer PALO ALTO, Calif., Sept. 24, 2025 (Korea Bizwire) – Denodo, a leader in data management, announced the availability of a new study conducted by independent analyst firm Veqtor8. The study compared the ROI of using the Denodo [...]

Heathrow Reigns as World’s Most Connected Airport in OAG Megahubs Tenth Anniversary Ranking

Heathrow Reigns as World’s Most Connected Airport in OAG Megahubs Tenth Anniversary Ranking

Heathrow (LHR) is top ranked for a third consecutive year. Istanbul (IST) climbs six places from 2024 to second ranked Megahub in 2025. Asia dominates low-cost with Kuala Lumpur (KUL) top for low-cost connections. LONDON, Sept. 24, 2025 (Korea Bizwire) – OAG, the world’s leading data platform for the global travel industry, today released Megahubs 2025. [...]

Kuala Lumpur Leads as Asia Pacific’s Most Connected Airport in OAG Megahubs

Kuala Lumpur Leads as Asia Pacific’s Most Connected Airport in OAG Megahubs

SINGAPORE, Sept. 23, 2025 (Korea Bizwire) –  OAG, the world’s leading data platform for the global travel industry, today released Megahubs 2025, its definitive ranking of the world’s most connected airports. Now in its tenth year, the report highlights the growing strength of Asia Pacific’s aviation sector, with three airports in the global Top 10. Kuala [...]

Axi Select Celebrates Two Years with $400M+ in Trader Funding and Breakthrough Success Stories

Axi Select Celebrates Two Years with $400M+ in Trader Funding and Breakthrough Success Stories

SYDNEY, Sept. 23, 2025 (Korea Bizwire) – Axi Select, the pioneering trader development and funding program from global online trading broker Axi, is celebrating its second anniversary with a major milestone — surpassing $400 million in allocated trader funding and cementing its position as the industry’s most innovative prop-style broker-backed program. Since launching in 2023, Axi Select has [...]

World Nears Quarter Million Crypto Millionaires in Historic Wealth Boom

World Nears Quarter Million Crypto Millionaires in Historic Wealth Boom

LONDON, Sept. 23, 2025 (Korea Bizwire) – The ranks of crypto millionaires have surged to an unprecedented 241,700 individuals worldwide, according to the newly released Crypto Wealth Report 2025 by international residence and citizenship advisory specialists Henley & Partners. That’s a remarkable 40% increase in just 12 months, fueled by a dramatic surge in Bitcoin millionaires — up [...]

First European Participants Randomized in AskBio Phase 2 Gene Therapy Trial of AB-1005 for Parkinson’s Disease

First European Participants Randomized in AskBio Phase 2 Gene Therapy Trial of AB-1005 for Parkinson’s Disease

Research Triangle Park, N.C., Sept. 22, 2025 (Korea Bizwire) – AB-1005, a glial cell line-derived neurotrophic factor (GDNF) investigational gene therapy, is being evaluated for the treatment of moderate-stage Parkinson’s disease in the REGENERATE-PD trial   Sites in Poland and the United Kingdom have started randomizing participants, with sites in Germany actively screening and following shortly  [...]

WHO Disenfranchises the Public from Tobacco Control Conference as Registration Barriers Reach “Insane” Levels

WHO Disenfranchises the Public from Tobacco Control Conference as Registration Barriers Reach “Insane” Levels

MANILA, Philippines, Sept. 22, 2025 (Korea Bizwire) – The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) today condemned the World Health Organisation’s Framework Convention on Tobacco Control (WHO FCTC) for erecting deliberate barriers to prevent public participation in the upcoming Conference of the Parties (COP11) scheduled for November in Geneva. Executive Coordinator Nancy [...]

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-’749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-’749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

  Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with olanzapine LAI (TEV-’749) and its long-term systemic safety profile was consistent with other olanzapine formulations1 Additional new data comparing initiation of UZEDY® (risperidone) versus Invega Sustenna® (paliperidone palmitate) in hospitalized patients found that UZEDY was associated with [...]